Connect with us

PR Newswire

Pomerantz Law Firm Announces the Filing of a Class Action against Decision Diagnostics Corporation and Certain Officers – DECN

Avatar

Published

on

NEW YORK, Jan. 15, 2021 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Decision Diagnostics Corporation (“Decision Diagnostics” or the “Company”) (OTCMKTS: DECN) and certain of its officers. The class action, filed in United States District Court for the Central District of California, and docketed under 21-cv-00418, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Decision Diagnostics securities between March 3, 2020 and December 17, 2020, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are a shareholder who purchased Decision Diagnostics securities during the Class Period, you have until March 16, 2021 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

[Click here for information about joining the class action]

Decision Diagnostics purportedly offers, among other products and services, prescription and non-prescription diagnostics and home testing products.

From March 2020 to at least June 2020, Defendants claimed that the Company had developed a finger-prick blood test that could detect COVID-19 in less than one minute. Defendants also made various representations regarding the Company’s progress towards achieving U.S. Food and Drug Administration (“FDA”) emergency use authorization (“EUA”) for this purported COVID-19 finger-prick blood test.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements, and failed to disclose material adverse facts about the Company’s business, operational, and compliance policies. Specifically, Defendants made false and/or misleading statements and failed to disclose to investors that: (i) Decision Diagnostics had not developed any viable COVID-19 test, much less a test that could detect COVID-19 in less than one minute; (ii) the Company could not meet the FDA’s EUA testing requirements for its purported COVID-19 test; (iii) accordingly, Defendants had misrepresented the timeline within which it could realistically bring its COVID-19 test to market; (iv) all the foregoing subjected Defendants to an increased risk of regulatory oversight and enforcement; and (v) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

On December 17, 2020, the SEC filed a complaint in federal court against Defendants, alleging that they had issued a series of press releases that falsely claimed that Decision Diagnostics had developed a finger-prick blood test that could detect COVID-19 in less than one minute (the “SEC Complaint”). According to the SEC Complaint, from March 2020 to at least June 2020, Defendants made false and misleading statements about the existence of Decision Diagnostics’ COVID-19 device and progress towards achieving FDA EUA for that device.  As alleged, at the time of these claims, Decision Diagnostics lacked a proven method for detecting the virus and had no physical testing device.  The SEC Complaint further alleged that the statements created the misleading impression that Decision Diagnostics would soon introduce the COVID-19 test to the market, which led to surges in the price and trading volume of the Company’s stock.

Following the filing of the SEC Complaint, Decision Diagnostics’ common share price fell $0.06 per share, or 60%, to close at $0.04 per share on December 18, 2020.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected] 
888-476-6529 ext. 7980

SOURCE Pomerantz LLP

Related Links

www.pomerantzlaw.com

Source: https://www.prnewswire.com:443/news-releases/pomerantz-law-firm-announces-the-filing-of-a-class-action-against-decision-diagnostics-corporation-and-certain-officers—decn-301209620.html

PR Newswire

Former Chief Economist of the SEC and Online Trading Academy Comment that for Retail Traders, Not all Education is Equal

Avatar

Published

on

IRVINE, Calif., March 2, 2021 /PRNewswire/ — In the Government hearings of the US House Committee on Financial Services beginning last week titled, “Game Stopped? Who Wins and Loses When Short Sellers, Social Media, and Retail Investors Collide?”, we heard a lot about the importance of…

Source: https://www.prnewswire.com:443/news-releases/former-chief-economist-of-the-sec-and-online-trading-academy-comment-that-for-retail-traders-not-all-education-is-equal-301238392.html

Continue Reading

PR Newswire

MEDIA ALERT: Equinix, VMware, NS1 and Leading Analyst Firm to Participate in “What Is at the Edge and Why Does Proximity Matter?” Webinar

Avatar

Published

on

REDWOOD CITY, Calif., March 2, 2021 /PRNewswire/ — Equinix, Inc. (Nasdaq: EQIX), the world’s digital infrastructure company™, today announced an upcoming virtual roundtable “What Is at the Edge and Why Does Proximity Matter?” with C-suite executives featuring speakers from Equinix,…

Source: https://www.prnewswire.com:443/news-releases/media-alert-equinix-vmware-ns1-and-leading-analyst-firm-to-participate-in-what-is-at-the-edge-and-why-does-proximity-matter-webinar-301238385.html

Continue Reading

PR Newswire

Retired Judge Richard B. ‘Rick’ Orfinger Joins Upchurch Watson White & Max

Avatar

Published

on

ORMOND BEACH, Fla., March 2, 2021 /PRNewswire/ — Richard B. “Rick” Orfinger retired after 20 years as a judge on the Fifth District Court of Appeal at the end of January and early the next month embarked on his career as a full-time neutral with Upchurch Watson White & Max Mediation…

Source: https://www.prnewswire.com:443/news-releases/retired-judge-richard-b-rick-orfinger-joins-upchurch-watson-white–max-301238140.html

Continue Reading

PR Newswire

CCTV+: Классики, цитируемые Си Цзиньпином: почему люди поддерживают КПК?

Avatar

Published

on

ПЕКИН, 2 марта 2021 г. /PRNewswire/ — В одном из гарвардских исследований, опубликованных в июле прошлого года, сообщалось, что Коммунистическая партия Китая (КПК) имеет высокий уровень поддержки и удовлетворенности среди китайского населения, превышающий 93%. С момента основания КПК 1…

Source: https://www.prnewswire.com:443/news-releases/cctv-klassiki-tsitiruemye-si-tszin-pinom-pochemu-liudi-podderzhivaiut-kpk–825371284.html

Continue Reading
Bioengineer5 days ago

Bioinformatics tool accurately tracks synthetic DNA

Bioengineer4 days ago

Unburdening China of cancer: Trend analysis to assist prevention measures

Nano Technology4 days ago

CEA-Leti & Dolphin Design Report FD-SOI Breakthrough that Boosts Operating Frequency by 450% and Reduces Power Consumption by 30%: Joint Paper Presented at ISSCC 2021 Shows How New Adaptive Back-Biasing Technique Overcomes Integration Limits in Chip Design Flows

AR/VR5 days ago

You Can Now Activate Quest Voice Commands Hands-free, But You’ll Have to Say “Hey Facebook”

AR/VR5 days ago

‘Virtual Desktop’ Can Now Stream PC VR Games to Quest, Without the Sideloading Workaround

AR/VR5 days ago

VR’s 2021 Outlook: 14 Indicators in One Place

Nano Technology5 days ago

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor

Automotive5 days ago

SpaceX swaps “suspect” Starship engine in record time

Bioengineer5 days ago

The key to proper muscle growth

Automotive5 days ago

Tesla Model X refresh units are gathering at Fremont ahead of customer deliveries

NEWATLAS5 days ago

Review: Hachi Infinite M1 Pro interactive ultra-short-throw projector

Energy4 days ago

New Columbia Solar raises $75 million, looks to develop 50 projects in D.C.

Cleantech5 days ago

New research method reveals significant reduction in carbon footprint of British pig farms

Amb Crypto5 days ago

Nasdaq-listed Ebang announces Litecoin, Dogecoin mining plans

Nano Technology5 days ago

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor

Bioengineer5 days ago

Retroviruses are re-writing the koala genome and causing cancer

Energy4 days ago

Washington State awards low-income solar project grants

Blockchain5 days ago

PlasmaPay launches decentralised exchange ‘PlasmaSwap’

Cleantech5 days ago

“Global warming won’t wait until 2050,” says European science advisory group

Bioengineer5 days ago

URI researchers: Microbes deep beneath seafloor survive on byproducts of radioactive process

Trending